Jupiter Neurosciences Inc
NASDAQ:JUNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jupiter Neurosciences Inc
NASDAQ:JUNS
|
US |
|
Cosmax BTI Inc
KRX:044820
|
KR |
|
T
|
Telefonica Deutschland Holding AG
XBER:O2D
|
DE |
|
G
|
Grupo Minsa SAB de CV
BMV:MINSAB
|
MX |
|
Premier Financial Corp (OHIO)
NASDAQ:PFC
|
US |
|
S
|
SPARQ Corp
XTSX:SPRQ
|
CA |
|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
US |
|
C
|
Corvus Pharmaceuticals Inc
F:C17
|
US |
|
R
|
Rainbow Tours SA
F:1X6
|
PL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JUNS's stock price target?
Not Available
JUNS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Jupiter Neurosciences Inc?
Projected CAGR
1 755%
Over the last 5 years, the compound annual growth rate for Revenue has been -55%. The projected CAGR for the next 2 years is 1 755%.
What is the Gross Profit forecast for Jupiter Neurosciences Inc?
Projected CAGR
1 500%
The compound annual growth rate for Gross Profit over the next 2 years is 1 500%.